EMA

EMA Other Income/Expenses (Net)

-$532.75MTTM · CAD

Period ending:

EMA FY Other Income/Expenses (Net)CAD
EMA FY Other Income/Expenses (Net)1993-12-31: -$700.10M1994-12-31: -$707.90M1995-12-31: -$711.70M1996-12-31: -$730.60M1997-12-31: -$741.40M1998-12-31: -$750.80M1999-12-31: -$146.60M2000-12-31: -$145.50M2001-12-31: -$153.60M2002-12-31: -$184.90M2003-12-31: -$182.90M2004-12-31: -$145.10M2005-12-31: -$125.00M2006-12-31: -$119.00M2007-12-31: -$105.90M2008-12-31: -$108.00M2009-12-31: -$121.30M2010-12-31: -$142.70M2011-12-31: -$82.00M2012-12-31: -$113.30M2013-12-31: -$108.50M2014-12-31: -$100.90M2015-12-31: $37.00M2016-12-31: -$311.00M2017-12-31: -$599.00M2018-12-31: -$582.00M2019-12-31: -$572.00M2020-12-31: $178.00M2021-12-31: -$375.00M2022-12-31: -$435.00M2023-12-31: -$621.00M2024-12-31: -$671.00M2025-12-31: -$384.69M$178.00M-$750.80M
1993-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in CAD. Dates are period ends; a fiscal year may differ from a calendar year.

EMA other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 33 observations from Dec 31, 1993 to Dec 31, 2025.

Emera Incorporated Common Shares Other Income/Expenses (Net) — Annual fiscal periods (CAD)
Period endingOther Income/Expenses (Net) (CAD)
-384,686,250
-671,000,000
-621,000,000
-435,000,000
-375,000,000
178,000,000
-572,000,000
-582,000,000
-599,000,000
-311,000,000
37,000,000
-100,900,000
-108,500,000
-113,300,000
-82,000,000
-142,700,000
-121,300,000
-108,000,000
-105,900,000
-119,000,000
-125,000,000
-145,100,000
-182,900,000
-184,900,000
-153,600,000
-145,500,000
-146,600,000
-750,800,000
-741,400,000
-730,600,000
-711,700,000
-707,900,000
-700,100,000

Compare other income/expenses (net)

All EMA financial metrics · EMA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.